CAS-backed X-ray technology developer XpectVision Technology has added $14.2m to its coffers to drive the development of its mammography device.
Gene therapy developer Renovacor, a Temple University spinout, has secured series A funding from investors including Novartis Venture Fund.
Royal Vopak, Mitsubishi and Covestro helped the Erlangen–Nuremberg hydrogen storage technology spinout collect $19m in funding.
UVC Partners has backed a $13.5m round that came four years after the diagnostic technology spinout of LMU secured a series B featuring UnternehmerTUM.
OUP, Celgene and Astellas Venture Management all supplied a portion of the funding to bring the Caltech-founded cancer drug developer's lifetime funding to $92m.
Mobility analytics provider Teralytics, an ETH Zurich spinout, has added funding from investors including Robert Bosch Venture Capital and Atomico.
Stanford University has backed a $12m series A for identity management technology developer Truework, which has been expanding its business in the employment and loan referencing space.
PredictImmune, a Cambridge spinout, added series B capital from investors including Cambridge Enterprise and CIC to $6.1m in series A funding raised last April.